Furthermore, it integrates data on antibody developability and antigen-drug target relationships, making it valuable for assisting new antibody therapies development. Notably, the database includes ...

New evidence suggests at least for some patients, the answer is yes. Researchers have discovered a potential antigen involved in the development of IC with Hunner lesions, they reported here at ...

The timeline of nanobody development reflects a steady series of innovations. In 2001, the term "nanobody" was introduced by ...

Anti-Aβ antibodies (Aβ-Abs) that bind specific Aβ variants are essential research tools. Furthermore, the monoclonal Aβ-Abs Aducanumab, Lecanemab, and Donanemab have recently gained approval as the ...

is pleased to announce today new benchmarking results that validate the accuracy and utility of its in silico epitope mapping application, part of the LENS ai ™ platform, with a direct ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

Precise epitope data also enhances experimental accuracy and reproducibility. 3 For instance, choosing antibodies for cleaved versus intact proteins, or for intracellular versus extracellular domains, ...